Certara (CERT) announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical and statistical programmers to efficiently create, reuse, and manage required data specifications for creating the CDISC Study Data Tabulation Model and Analysis Data Model datasets. These datasets are required when sponsors present their study safety and efficacy results and analysis to regulators.Traditional, spreadsheet-based methods of managing specifications are prone to errors, lack version control, and hinder collaboration. Pinnacle 21 Enterprise Plus directly addresses these challenges by offering a unified, collaborative workspace that accelerates the journey from source data to submission-ready datasets. The no-code interface is set to deliver a 50% reduction in time spent drafting mapping specifications, according to internal measurements.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara, Inc. Reports Strong Q2 2025 Earnings Growth
- Certara’s Mixed Signals: Hold Rating Amidst Growth Potential and Strategic Uncertainty
- Certara, Inc. Reports Strong Q2 2025 Growth
- Certara’s Strong Q2 Performance and Strategic Positioning Drive Buy Rating
- Certara reports Q2 adjusted EPS 7c, consensus 10c
